IMVT CIK: 1764013

Immunovant, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
−106
FY23:
−188
FY24:
−214
FY25:
−376
FY26:
−407
Change from FY22 to FY26
millions USD
FY22:
−0.25
FY23:
−0.20
FY24:
−0.36
FY25:
−0.76
FY26:
−0.01
Change from FY22 to FY26
millions USD
FY22:
200
FY23:
70.9
FY24:
472
FY25:
454
FY26:
596
millions USD
FY22:
93.7
FY23:
−117
FY24:
259
FY25:
78.6
FY26:
188
(positive)
Change from FY22 to FY26
millions USD
FY22:
−106
FY23:
−188
FY24:
−215
FY25:
−377
FY26:
−407

All amounts in millions USD Data source:SEC EDGAR